Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab

Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) from using anti-interleukin (IL)-1 has not been reported in the literature, to our knowledge. We herein report a case of paradoxical HS as a result of use of anti-IL-1 agents for mevalonate kinase deficiency disease that was successf...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 48; no. 5; pp. 535 - 536
Main Authors López Sanz, Pablo, Guzmán Pérez, Marta, Azaña Defez, José Manuel, Guerrero Ramírez, Claudia, Manso Córdoba, Silvia, Alfaro Martínez, María Encarnación
Format Journal Article
LanguageEnglish
Published England 27.04.2023
Subjects
Adalimumab
Hidradenitis Suppurativa - drug therapy
Humans
Interleukin-1
Mevalonate Kinase Deficiency
Ustekinumab - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) from using anti-interleukin (IL)-1 has not been reported in the literature, to our knowledge. We herein report a case of paradoxical HS as a result of use of anti-IL-1 agents for mevalonate kinase deficiency disease that was successfully treated with the addition of ustekinumab.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0307-6938
1365-2230
DOI:10.1093/ced/llad003